Title : LncRNA UCA1 promotes cisplatin resistance in gastric cancer via recruiting EZH2 and activating PI3K/AKT pathway.

Pub. Date : 2020

PMID : 32328192






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 LncRNA UCA1 promotes cisplatin resistance in gastric cancer via recruiting EZH2 and activating PI3K/AKT pathway. Cisplatin AKT serine/threonine kinase 1 Homo sapiens
2 Hence, UCA1 promotes cisplatin resistance of GC via recruiting EZH2 and activating PI3K/AKT pathway. Cisplatin AKT serine/threonine kinase 1 Homo sapiens
3 Conclusion: Our research revealed the lncRNA UCA1 promoted the cisplatin resistance of GC by recruiting EZH2 and activating PI3K/AKT pathway to modulate cell apoptosis, indicating treatments targeting UCA1 or EZH2 might provide meaningful therapeutic strategies for cisplatin-resistance GC patients. Cisplatin AKT serine/threonine kinase 1 Homo sapiens